From: Jeffrey Epstein <[email protected]> To: Ian Osborne Subject: Fwd: Jawbone/Mort Date: Thu, 06 Sep 2012 10:52:04 +0000 Ill review all in detail , when i land tonight , in ny for the next week, you? Forwarded messa e From: Darren Indyke Date: Wed, Sep 5, 2012 at 8:17 PM Subject: Fwd: Jawbone/Mort To: Jeffrey Epstein <[email protected]> Sent from my iPhone Begin forwarded message: From: "Jacoby, Craig" < Date: September 5, 2012 7:27:21 PM EDT To: "Darren Indyke" Cc: "Hosain Rahman" Subject: Jawbone/Mort Hi Darren, "Ian Osborne" < >, "Jacoby, Craig" Just checking back in on the Jawbone investment. Thanks for sending across your comments. If possible, we would like to avoid a situation where we recirculate the investment agreements in place with Jawbone's other investors, and our hope is that we can accommodate as many of your comments as possible short of taking that step. We think that the best way to address your comments would be to have Jawbone enter into a new purchase agreement covering both the preferred and the common stock being sold to Mort. Jawbone would make its representations and warranties anew upon the closing of the purchase agreement, so Mort would not be relying on the reps made back in June 2011, nor on the schedule of exceptions prepared in connection with the initial closing. The new purchase agreement would have the same closing conditions that applied to the initial closing of the JP Morgan investment. Given the affiliation between Mort, Hedosophia and Apoletto and their collective investment in preferred and common stock, we also want to propose that Mort (along with the other two parties) be treated as a "Major Investor" under the Investor Rights Agreement so long as their collective holdings of preferred and common stock remains at least equal to 2,000,000 shares. We intend to do this with a side letter that would not require the signature of the other parties to those documents. You have already